BioXcel Therapeutics, Inc. drugs

1 result
  • igalmi

    (DEXMEDETOMIDINE)
    BioXcel Therapeutics, Inc.
    IGALMI is indicated for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Its safety and effectiveness have not been established beyond 24 hours from the first dose.